.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Mallinckrodt
Cerilliant
Cantor Fitzgerald
Johnson and Johnson
McKesson
UBS
Chinese Patent Office
Dow
AstraZeneca

Generated: September 19, 2017

Patent: ► Subscribe

Summary for Patent: ► Subscribe

Title:Human antibodies and antibody-drug conjugates against CD74
Abstract: Isolated human monoclonal antibodies which bind to human CD74 and related antibody-drug conjugates are disclosed. Pharmaceutical compositions comprising the antibodies or antibody-drug conjugates, and therapeutic and diagnostic methods for using the antibodies and/or antibody-drug conjugates, are also disclosed.
Inventor(s): Verploegen; Sandra (Nieuwegein, NL), Overdijk; Marije (Utrecht, NL), Dijkhuizen; Riemke Van (Zeist, NL), Bleeker; Willem Karel (Amsterdam, NL), Van Berkel; Patrick (Utrecht, NL), Parren; Paul (Odijk, NL), Lisby; Steen (Frederiksberg, DK)
Assignee: GENMAB A/S (Copenhagen, DK)
Application Number:13/982,959
Patent Claim Types:
see list of patent claims
Composition; Use;

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Inventors Patent Expiration Status Orphan Source
Merck
ELSPAR
asparaginase
VIAL1010630011978-01-10► Subscribe GENMAB A/S (Copenhagen, DK) Verploegen; Sandra (Nieuwegein, NL), Overdijk; Marije (Utrecht, NL), Dijkhuizen; Riemke Van (Zeist, NL), Bleeker; Willem Karel (Amsterdam, NL), Van Berkel; Patrick (Utrecht, NL), Parren; Paul (Odijk, NL), Lisby; Steen (Frederiksberg, DK) ► SubscribeRXsearch
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Summary for Patent: ► Subscribe

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Denmark2011 00064Feb 1, 2011
PCT Information
PCT FiledFebruary 01, 2012PCT Application Number:PCT/EP2012/051679
PCT Publication Date:August 09, 2012PCT Publication Number: WO2012/104344

International Patent Family for Patent: ► Subscribe

Country Document Number Publication Date
Australia2012213437Aug 18, 2016
Australia2012213437May 02, 2013
Canada2826186Aug 09, 2012
China103458930Dec 18, 2013
European Patent Office2670440Dec 11, 2013
Israel227477Sep 30, 2013
Japan2014507138Mar 27, 2014
Mexico2013008832Sep 06, 2013
Russian Federation2013140433Mar 10, 2015
Singapore10201608138RNov 29, 2016
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Healthtrust
QuintilesIMS
McKinsey
Merck
Chinese Patent Office
Daiichi Sankyo
Teva
Farmers Insurance
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot